{"article":{"annotation":{"article_id":"brazil-hemobras-immunoglobulin-supply-agreement-october-2026","available_at":"2026-10-07T03:14:20.471008Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"cf5fb16c6f493a73de521a8b79e1c78af8a39e1cb7a4eb62cad8df3582b0f06a","input_sha256":"e75cc3cbd1d14a9b2081d5dbd4549b144ec237b42e13124544a14d0fd34deb2e","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[{"admin1":null,"city":null,"coordinate_note":null,"coordinate_reference_system":"OGC:CRS84","coordinate_source":null,"country":"BR","evidence":[{"field":"country","language":"en","note":"Explicit preserved editorial country/region; no city or national centroid inferred","source_urls":["https://www.gov.br/saude/pt-br/assuntos/noticias-ms/2026/outubro/brasil-firma-acordo-para-ampliar-producao-de-imunoglobulina-medicamento-para-doencas-do-sangue/"]}],"geometry":null,"id":"iso3166-1:BR","kind":"country-or-area","labels":{"ar":"البرازيل","en":"Brazil","es":"Brasil","fr":"Brésil"},"match_status":"candidate","precision":"regional","role":"coverage","uncertainty_m":null}],"rules_sha256":"d28c9c89703b56bd91fd887965d416d0115c2473d4bfbd3e558bcceafc3941dd","schema_version":1,"subjects":[{"concept_id":"medtop:13000000","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: technology","source_urls":["https://www.gov.br/saude/pt-br/assuntos/noticias-ms/2026/outubro/brasil-firma-acordo-para-ampliar-producao-de-imunoglobulina-medicamento-para-doencas-do-sangue/"]}],"method":"controlled-rules-v1","rule_id":"technology","status":"candidate"},{"concept_id":"medtop:07000000","confidence":null,"confidence_method":null,"evidence":[{"field":"category+topics","language":"en","note":"Preserved editorial category/topic; broad candidate only","source_urls":["https://www.gov.br/saude/pt-br/assuntos/noticias-ms/2026/outubro/brasil-firma-acordo-para-ampliar-producao-de-imunoglobulina-medicamento-para-doencas-do-sangue/"]}],"method":"controlled-rules-v1","rule_id":"health-broad","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026?lang=fr","category":"health","content":{"key_points":[],"paragraphs":["Le ministère brésilien de la Santé a indiqué que Hemobrás et la société chinoise Tiantan Bio ont signé à São Paulo, le 2 octobre, un accord de coopération visant à élargir les sources d’approvisionnement en immunoglobulines. L’accord établit un cadre pour l’enregistrement au Brésil, l’approvisionnement en immunoglobuline humaine intraveineuse, ainsi que la concession et le transfert de technologie.","Les modalités d’approvisionnement et de transfert seront définies dans des accords distincts et soumises aux exigences de l’Anvisa. Le ministère a aussi indiqué que la modernisation des équipements devrait augmenter d’environ 30 % la capacité de stockage du plasma ; 604 équipements ont été distribués à 125 services d’hémothérapie et 38 millions de réaux ont été alloués à l’amélioration des centres sanguins."],"sections":[]},"corrections":[{"at":"2026-10-07T00:51:14+03:00","language":"fr","text":"Des éditions allemande et portugaise, ainsi que les traductions des explications des données et des corrections, ont été ajoutées à cet article."},{"at":"2026-10-07T05:57:01+03:00","language":"fr","text":"Classification des données ajoutée : chaque chiffre porte désormais un identifiant de mesure avec son unité, sa zone géographique, sa fréquence et son type. Aucun chiffre, unité ou date n’a changé."}],"country":"BR","data":{"blocks":[{"description":{"ar":"النتائج والتمويل الواردان في إعلان وزارة الصحة بتاريخ 2 أكتوبر.","de":"Ergebnisse und Mittelzuweisungen aus der Mitteilung des Gesundheitsministeriums vom 2. Oktober.","en":"Outcomes and allocations stated in the Health Ministry’s October 2 notice.","es":"Resultados y asignaciones indicados en el anuncio ministerial del 2 de octubre.","fr":"Résultats et allocations indiqués dans l’annonce du ministère le 2 octobre.","pt":"Resultados e recursos alocados conforme comunicado do Ministério da Saúde de 2 de outubro.","tr":"Sağlık Bakanlığının 2 Ekim duyurusunda belirtilen sonuç ve kaynaklar."},"id":"brazil-immunoglobulin-agreement-data","items":[{"basis":"estimate","label":{"ar":"الزيادة المتوقعة في السعة","de":"Erwarteter Kapazitätszuwachs","en":"Capacity increase expected","es":"Aumento de capacidad previsto","fr":"Hausse de capacité attendue","pt":"Aumento de capacidade esperado","tr":"Beklenen kapasite artışı"},"measure":{"aggregation":"change","frequency":"irregular","geography":"brazil","id":"brazil-hemobras-immunoglobulin-capacity-increase","periodRole":"announcement-date","unitCode":"percent"},"period":"2026-10-02","unit":"%","value":30.0,"valueQualifier":"approximate"},{"basis":"observed","label":{"ar":"التمويل المخصص لخدمات مراكز الدم","de":"Zugewiesene Mittel für Blutzelldienste","en":"Blood-center service funding allocated","es":"Financiación asignada a centros de sangre","fr":"Financement alloué aux centres sanguins","pt":"Recursos destinados aos serviços de hemocentros","tr":"Hemocenter hizmetleri için ayrılan kaynak"},"measure":{"aggregation":"stock","frequency":"irregular","geography":"brazil","id":"brazil-blood-center-service-funding","periodRole":"announcement-date","unitCode":"million-brl"},"period":"2026-10-02","unit":"million BRL","value":38},{"basis":"observed","label":{"ar":"المعدات الموزعة","de":"Verteilte Ausrüstung","en":"Equipment distributed","es":"Equipos distribuidos","fr":"Équipements distribués","pt":"Equipamentos distribuídos","tr":"Dağıtılan ekipman"},"measure":{"aggregation":"stock","frequency":"irregular","geography":"brazil","id":"brazil-blood-center-equipment-distributed","periodRole":"announcement-date","unitCode":"count"},"period":"2026-10-02","unit":"count","value":604},{"basis":"observed","label":{"ar":"الخدمات التي تلقت المعدات","de":"Dienste mit erhaltener Ausrüstung","en":"Services receiving equipment","es":"Servicios que recibieron equipos","fr":"Services ayant reçu des équipements","pt":"Serviços que receberam equipamentos","tr":"Ekipman alan hizmet birimi"},"measure":{"aggregation":"stock","frequency":"irregular","geography":"brazil","id":"brazil-blood-center-services-equipped","periodRole":"announcement-date","unitCode":"count"},"period":"2026-10-02","unit":"count","value":125}],"methodology":{"ar":"نسبة 30% سعة متوقعة تقريبية؛ والتمويل والمعدات والخدمات إجماليات إدارية أبلغت عنها الوزارة.","de":"Die rund 30 Prozent beziehen sich auf die erwartete Kapazität; Finanzierung, Ausrüstung und erfasste Dienste sind vom Ministerium gemeldete Verwaltungszahlen.","en":"The approximate 30% is expected capacity; funding, equipment and service coverage are administrative totals reported by the ministry.","es":"El 30% es una capacidad prevista aproximada; la financiación, equipos y servicios son totales administrativos informados por el ministerio.","fr":"Les 30 % représentent une capacité attendue approximative ; les financements, équipements et services sont des totaux administratifs communiqués par le ministère.","pt":"Os cerca de 30% referem-se à capacidade esperada; financiamento, equipamentos e serviços cobertos são totais administrativos informados pelo ministério.","tr":"Yaklaşık yüzde 30 artış beklenen kapasitedir; ödenek, dağıtılan ekipman ve hizmet kapsamı bakanlığın bildirdiği idari toplamdır."},"sourceUrls":["https://www.gov.br/saude/pt-br/assuntos/noticias-ms/2026/outubro/brasil-firma-acordo-para-ampliar-producao-de-imunoglobulina-medicamento-para-doencas-do-sangue/"],"title":{"ar":"استثمار مراكز الدم وقدرتها","de":"Investitionen und Kapazität von Blutzentren","en":"Blood-center investment and capacity","es":"Inversión y capacidad de centros de sangre","fr":"Investissement et capacité des centres sanguins","pt":"Investimento e capacidade de hemocentros","tr":"Hemocenter yatırımı ve kapasite"},"type":"metrics","updatedAt":"2026-10-07T00:51:14+03:00"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026/data/brazil-immunoglobulin-agreement-data?lang=fr&format=csv","json":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026/data/brazil-immunoglobulin-agreement-data?lang=fr&format=json"},"id":"brazil-immunoglobulin-agreement-data"}],"data_types":["metrics"],"editorial_illustration":{"alt":"Illustration conceptuelle de la santé publique, de la recherche et des données connectées.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"fr","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"event_id":"event-0ffced43-7698-5eba-a00e-d2a78030ca83","event_period":"2026-10-02","event_period_basis":"event-or-reference-period","id":"brazil-hemobras-immunoglobulin-supply-agreement-october-2026","image":null,"importance":0.6,"language":"fr","modified_at":"2026-10-07T05:57:01+03:00","publication_basis":"publication-record","published_at":"2026-10-06T17:11:49+00:00","reading_minutes":1,"region":"world","section_illustration":{"alt":"Illustration conceptuelle de la santé publique, de la recherche et des données connectées.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"fr","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"slug":"brazil-hemobras-immunoglobulin-supply-agreement-october-2026","sources":[{"checkedAt":"2026-10-06","name":"Ministry of Health of Brazil","publishedAt":"2026-10-02","url":"https://www.gov.br/saude/pt-br/assuntos/noticias-ms/2026/outubro/brasil-firma-acordo-para-ampliar-producao-de-imunoglobulina-medicamento-para-doencas-do-sangue/"}],"summary":"La coopération entre Hemobrás et Tiantan Bio porte sur l’approvisionnement du médicament dérivé du plasma et un transfert de technologie envisagé.","text":"La coopération entre Hemobrás et Tiantan Bio porte sur l’approvisionnement du médicament dérivé du plasma et un transfert de technologie envisagé.\n\nLe ministère brésilien de la Santé a indiqué que Hemobrás et la société chinoise Tiantan Bio ont signé à São Paulo, le 2 octobre, un accord de coopération visant à élargir les sources d’approvisionnement en immunoglobulines. L’accord établit un cadre pour l’enregistrement au Brésil, l’approvisionnement en immunoglobuline humaine intraveineuse, ainsi que la concession et le transfert de technologie.\n\nLes modalités d’approvisionnement et de transfert seront définies dans des accords distincts et soumises aux exigences de l’Anvisa. Le ministère a aussi indiqué que la modernisation des équipements devrait augmenter d’environ 30 % la capacité de stockage du plasma ; 604 équipements ont été distribués à 125 services d’hémothérapie et 38 millions de réaux ont été alloués à l’amélioration des centres sanguins.\n\nDes éditions allemande et portugaise, ainsi que les traductions des explications des données et des corrections, ont été ajoutées à cet article.\n\nClassification des données ajoutée : chaque chiffre porte désormais un identifiant de mesure avec son unité, sa zone géographique, sa fréquence et son type. Aucun chiffre, unité ou date n’a changé.","title":"Le Brésil signe un accord pour élargir l’approvisionnement en immunoglobulines","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026?lang=en","language":"en","url":"https://newsverum.com/en/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026?lang=es","language":"es","url":"https://newsverum.com/es/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026?lang=de","language":"de","url":"https://newsverum.com/de/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026"}],"url":"https://newsverum.com/fr/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026"},"version":"1"}